Sweden· SE-19920904000068
Mifegyne 200 mg Tablett
A medicinal product containing mifepristone, registered in Sweden by Exelgyn, Paris.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Mifepristone
- Manufacturer
- Exelgyn, Paris
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19920904000068
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mifepristone in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsMifegyne 200 mg, tablettenEuro Registratie Collectief B.V.
- FinlandMifegyneParanova Oy
- CzechiaMIFEGYNEExelgyn, Paris
- United StatesMifepristoneGenBioPro, Inc.
- United KingdomMifegyne 200mg tabletsNordic Pharma Ltd
- SpainMIFEGYNE 200 mg COMPRIMIDOSExelgyn
- IrelandMifegyne 200 mg tabletsEXELGYN
- FranceMIFEGYNE 200 mg, compriméEXELGYN
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Mifegyne
- Belgium · Mifegyne
- Bulgaria · Мифегин
- Cyprus · Mifegyne
- Czechia · Mifegyne
- Germany · Mifegyne
- Denmark · Mifegyne
- Estonia · Mifegyne
- Spain · Mifegyne
- Finland · Mifegyne
- France · Mifegyne, Miffee
- United Kingdom (Northern Ireland) · Mifegyne, Mifepristone Linepharma
- Greece · Mifegyne
- Croatia · Mifegyne
- Ireland · Mifegyne
- Iceland · Mifegyne
- Italy · Mifegyne
- Lithuania · Mifegyne
- Luxembourg · Mifegyne
- Latvia · Mifegyne
- Netherlands · Mifegyne
- Norway · Mifegyne
- Portugal · Mifegyne
- Romania · Mifegyne
- Slovenia · Mifegyne
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/46041991-5b1c-4f44-a4eb-2e79a07f0ba3 GET /v1/drugs/46041991-5b1c-4f44-a4eb-2e79a07f0ba3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "19920904000068",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19920904000068",
"product_doc_link": "https://docetp.mpa.se/LMF/Mifegyne%20tablet%20SmPC_09001bee807a58ec.pdf"
}See everything about mifepristone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.